Calpains and human disease

Subcellular Biochemistry

Volumn 45, Issue , 2007, Pages 29-53

  Bertipaglia, I ^a   Carafoli, E ^a  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Calpain 10; Calpain 3; Muscular dystrophy; Neurodegeneration; Protease; Type 2 diabetes

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; CALPAIN; CALPASTATIN; CAPN3 PROTEIN, HUMAN; CONNECTIN; MUSCLE PROTEIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALPAIN; DIABETES MELLITUS, TYPE 2; HUMANS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; NEURODEGENERATIVE DISEASES; PROTEIN KINASES;

EID: 38849096603     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6191-2_2     Document Type: Article

References (141)

1. Alvarez, A., Toro, R., Caceres, A., Maccioni, R.B., 1999, Inhibition of tau phosphorylating protein kinase cdk5 prevents β amyloid-induced neuronal death, FEBS Lett., 459, 421-426
2. Anderson, L.V.B., Harrison, L.V.B., Pogue, R., Vafiadaki, E., Pollitt, C., Davison, K., Moss, J.A., Keers, S., Pyle, A., and Shaw, P.J., et al., 2000, Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)., Neuromuscul. Dis., 10, 553-559
3. Arrington, D., Van Vleet, T., Schnellmann, R., 2006, Calpain 10: A Mitochondrial Calpain and its Role in Calcium-induced Mitochondrial Dysfunction, Am. J. Physiol.Cell. Physiol
4. Baghdiguian, S., Martin, M., Richard, I., Pons, F., Astier, C., Bourg, N., Hay, R.T., Chemaly, R., Halaby, G., Loiselet, J., Anderson, L.V., Lopez de Munain, A., Fardeau, M., Mangeat, P., Beckmann, J.S., Lefranc, G., 1999, Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A, Nat Med., 5, 503-11
5. Baier, L.J., Permana, P.A., Yang X., Pratley, R.E., Hanson, R.L., Shen, G.Q., Mott, D., Knowler, W.C., Cox, N.J., Horikawa, Y., Oda, N., Bell, G.I., Bogardus, C., 2000, A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance, J. Clin. Invest., 106, 69-73
6. Baki, A., Tompa, P., Molnár, O., Friedrich, P., 1995, Autolysis parallels activation of μ-calpain, Biochem. J., 318, 897-901
7. Banik, N.L., Matzelle, D., Terry, E., Hogan, E.L., 1997, A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation, Brain. Res.; 748,205-210
8. Bano, D., Young, K.W., Guerin, C.J., LeFeuvre, R., Rothwell, N.J., Naldini, L., Rizzuto, R., Carafoli, E. and Nicotera, P., 2005, Cleavage of the plasma membrane Na(+)/Ca(2+) exchanger in excitotoxicity, Cell, 120, 275-285
9. Bansal, D., and Campbell, K.P., 2004, Dysferlin and the plasma membrane repair in muscular dystrophy., Trends Cell Biol., 14, 206-213
10. Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., and Argov, Z., et al., 1998, A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B., Nat. Genet., 20, 37-42
11. Beckmann, J.S., Richard, I., Hillaire, D., Broux, O., Antignac, C., Bois, E., Cann, H., Cottingham, R.W., Feingold, N., and Feingold, J., et al.,1991, A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage, C. R. Acad. Sci. III, 312, 141-148
12. Besse, S., Delcayre, C., Chevalier, B., Hardouin, S., Heymes, C., Bourgeois, F., Moalic, J.M., Swynghedauw, B., 1994, Is the senescent heart overloaded and already failing., Cardiovasc. Drugs Ther., 8, 581-587
13. Blalock, E.M., Porter, N.M., Landfield, P.W., 1999, Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures., J. Neurosci, 19, 8674-8684
14. Blanchard, H., Li, Y., Cygler, M., Kay, C.M., Simon, J., Blanchard, H., Li, Y., Cygler, M., Kay, C.M., Simon, J.C., Davies, P.L., Elce, J. S., 1996, Ca(2+)-binding domain VI of rat calpain is a homodimer in solution: hydrodynamic, crystallization and preliminary X-ray diffraction studies, Protein Sci., 5, 535-537
15. Blomgren, K., Zhu, C., Wang, X., et al., 2001, Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?, J. Biol. Chem., 276, 10191-10198
16. Branca, D., Gigliucci, A., Bano, D., Brini, M., Carafoli, E., 1999, Expression, partial purification and functional properties of the muscle specific calpain isoform p94, Eur. J. Biochem., 265, 839-46
17. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., Hof, P.R., 2000, Tau protein isoforms, phosphorylation and role in neurodegenerative disorders, Brain. Res. Rev., 33, 95-130
18. Bushby, K.M.D., 1999, Making sense of the limb-girdle muscular dystrophies, Brain,122, 1403-1420
19. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A., and Butler, P.C., 2003, ß-Cell Deficit and Increased ß-Cell Apoptosis in Humans With Type 2 Diabetes, Diabetes, 52, 102-110
20. Cai, D., Frantz, J.D., Tawa, N.E., P.A. Jr., Melendez, B.C., Oh, H.G., Lidov, P.O., Hasselgren, W.R., Frontera, J. and Lee, D.J. et al., 2004, IKKbeta/NF-kappaB activation causes severe muscle wasting in mice, Cell, 119, 285-298
21. Carafoli, E., and Molinari, M., 1998, Calpain: a protease in search of a function?, Biochem. Biophys. Res. Commun., 247, 193-203.
22. Chae, J., Minami, N., Jin, Y., Nakagawa, M., Murayama, K., Igarashi, F. and Nonaka, I., 2001, Calpain 3 gene mutations: genetic and clinical-pathologic findings in limb-girdle muscular dystrophy., Neuromuscul. Dis., 11, 547-555
23. Chen, M., and Fernandez, H.L., 2005, Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein., Biochem. Biophys. Res. Commun., 330, 714-21
24. Chrobakova, T., Hermanova, M., Kroupova, I., Vondracek, P., Marikova, T., Mazanec, R., Zamecnik, J., Stanek, J., Havlova, M. and Fajkusova, L., 2004, Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome, Neuromuscul. Disord., 14, 659-665
25. 2+-dependent protease, J. Biol. Chem., 259, 11627-11630
26. Cottin, P., Thompson, V., Sathe, S., Szpacenko, A., Goll, D., 2001, Autolysis of μ- and m-calpain from bovine skeletal muscle., Biol. Chem., 382, 767-776
27. Crocker, S.J., Smith, P.D., Jackson-Lewis, V., Lamba, W.R., Hayley, S.P., Grimm, E., Callaghan, S.M., Slack, R.S., Melloni, E., Przedborski, S., Robertson, G.S., Anisman, H., Merali, Z., Park, D.S., 2003, Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease, J. Neurosci., 23, 4081-4091
28. 2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle, Biochemistry, 15, 2150-2158
29. Dear, T.N., and Boehm, T., 2000, Identification and characterization of two novel calpain large subunit genes, Gene, 274, 245-252
30. Dear, T.N., and Boehm, T., 1999, Diverse mRNA expression patterns of the mouse calpain genes Capn5, Capn6, and Capn 11 during development, Mech. Dev., 89, 201-209
31. Diaz, B., Moldoveanu, T., Kuiper, M., Campbell, R., Davies, P., 2004, Insertion Sequence 1 of Musclespecific Calpain, p94, Acts as an Internal Propeptide, J. Biol. Chem., 279, 27656-27666
32. Fanin, M., Nascimbeni, A.C., Fulizio, L., Trevisan, C.P., Meznaric-Petrusa, M. and Angelini, C., 2003, Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression, Am. J. Pathol., 163, 1929-1936
33. Fokkema, I.F., den Dunnen, J.T., and Taschner, P.E., 2005, LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach, Hum.Mutat., 26, 63-68
34. Fougerousse, F., Gonin, P., Durand, M., Richard, I. and Raymackers, J.M., 2003, Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption, Muscle Nerve, 27, 616-623
35. 2+ dependency of calpain 3 (p94) activation, Biochemistry, 45, 3714-22
36. Garvey, S.M., Rajan, C., Lerner, A.P., Frankel, W.N. and Cox, G.A., 2002, The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin, Genomics, 79, 146-149
37. Gil-Parrado, S., Fernández-Montalván, A., Assfalg-Machleidt, I., Popp, O., Bestvater, F., Holloschi, A., Knoch, T.A., Auerswald, E.A., Welsh, K., Reed, J.C., Fritz, H., Fuentes-Prior, P., Spiess, E., Salvesen, G.S., Machleidt, W., 2002, Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members, J. Biol. Chem., 277, 27217-27226
38. Gil-Parrado, S., Popp, O., Knoch, T., Zahler, T., Bestvater, F., Felgenträger, M., Holloschi, A., Fernández-Montalavan, A., Auerswald, D., Fritzh, H., Fluentes-Prior, P., Machleidt, W., Spiess, E., 2003, Subcellular localization and in vivo subunit interactions of ubiquitous μ-calpain, J. Biol. Chem., 278
39. Goll, D.E., Thompson, V.F., Li, H., Wei, W., and Cong, J., 2003, The Calpain System, Physiol. Rev., 83, 731-801
40. Gonzalez, A., Abril, E., Roca, A., Aragon, M.J., Figueroa, M.J., Velarde, P., Royo, J.L., Real, L.M., Ruiz, A., CAPN10 alleles are associated with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 3971-3976
41. Gregorio, C., Granzier, H., Sorimachi, H., Labeit, S.,1999, Muscle assembly: a titanic achievement?, Curr. Opin. Cell. Biol., 11, 18-25
42. Griffin, M.E., Marcucci, M.J., Cline, G.W., Bell, K., Barucci, N., Lee, D., Goodyear, L.J., Kraegen, E.W., White, M.F., Shulman, G.I., 1999, Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48, 1270-4
43. Guroff, G., 1964, A neutral, calcium-activated proteinase from the soluble fraction of rat brain, J. Biol. Chem., 239, 149-55
44. Guyon, J.R., Kudryashova, E., Potts, A., Dalkilic, I., Brosius, M.A., Thompson, T.G., Beckmann, J.S., Kunkel, L.M. and. Spencer M.J., 2003, Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans., Muscle Nerve, 28, 472-483
45. Hanis, C.L., Boerwinkle, E., Chakraborty, R., Ellsworth, D.L., Concannon, P., Stirling, B., Morrison, V.A., Wapelhorst, B., Spielman, R.S., Gogolin-Ewens, K.J., Shephard, J.M., Williams, S.R., Risch, N., Hinds, D., Iwasaki, N., Ogata, M, Omori, Y., Petzold, C., Rietzch, H., Schroder, H.E., Schulze, J., Cox, N.J., Menzel, S., Boriraj, V.V., and Chen, X., et al., 1996, A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2., Nat. Genet., 13, 161-166
46. Haravuori, H., Vihola, A., Straub, V., Auranen, M., Richard, I., Marchand, S., Voit, T., Labeit, S., Somer, H. and Peltonen, L., et al., 2001, Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene, Neurology, 56, 869-877
47. Harris, F., Chatfield, L., Singh, J., Phoenix, D.A., 2004, Role of calpains in diabetes mellitus: a mini review, Mol. Cell. Biochem., 261, 161-7
48. 2+-dependent protease activity and a novel mode of enzyme activation, EMBO J., 18, 6880-6889
49. Hoffstedt, J., Naslund, E., Arner, P., 2002, Calpain-10 gene polymorphism is associated with Reduced β3-Adrenoceptor function in human fat cells., J. Clin. Endocr. Metab., 87, 3362-3367
50. Horikawa, Y., Oda, N., Cox, N.J., et al., 2000, Genetic varation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus, Nat. Genet., 26, 163-165
51. Illa, I., Serrano-Munuera, C., Gallardo, E., Lasa, A., Rojas-Garcia, R., Palmer, J., Gallano, P., Baiget, M., Matsuda, C., and Brown, R.H., 2001, Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype, Ann. Neurol., 49, 130-134
52. Inomata, M., Saito, Y., Kon, K., Kawashima, S., 1990, Binding sites for calcium-activated neutral protease on erythrocyte membranes are not membrane phospholipids. Biochem.Biophys. Res. Commun., 171, 625-632
53. Jia, Z., Petrounevitch, V., Wong, A., Moldoveanu, T., Davies, P.L., Elce, J.S., and Beckmann, J.S., 2001, Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain., Biophys. J., 80, 2590-2596
54. Johnson, J.D., Ahmed, N.T., Luciani, D. S., Han, Z., Tran, H., Fujita, J., Misler, S., Edlund, H., and Polonsky, K.S., 2003, Increased islet apoptosis in Pdx1+/- mice, J. Clin. Invest., 111, 1147-1160
55. Jordán, J., Galindo, M.F., Miller, R.J.,1997, Role of calpain- and interleukin-1 beta converting enzymelike proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture, J. Neurochem., 68, 1612-1621
56. Saito, K., Elce, J.S., Hamos, J.E., and Nixon, R.A., 1993, Widespread Activation of Calcium-Activated Neutral Proteinase (Calpain) in the Brain in Alzheimer Disease: A Potential Molecular Basis for Neuronal Degeneration, Proc. Natl. Acad. Sci. U. S. A., 90, 2628-2632
57. Kawai, H., Akaike, M., Kunishige, M., Inui, T., Adachi, K., Kimura, C., Kawajiri, M., Nishida, Y., Endo, I., and Kashiwagi, S. et al., 1998, Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families, Muscle Nerve, 21, 1493-1501
58. Kim, M.J., Jo, D.G., Hong, G.S., Kim, B.J., Lai, M., Cho, D.H., Kim, K.W., Bandyopadhyay, A., Hong, Y.M., Kim, D.H., Cho, C., Liu, J.O., Snyder, S.H., Jung, Y.K., 2002, Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death, Proc. Natl. Acad. Sci. USA, 99, 9870-9875
59. Kinbara, K., Ishiura, S., Tomioka, S., Sorimachi, H., Jeong, S.Y., Amano, S., Kawasaki, H., Kolmerer, B., Kimura, S., Labeit, S., Suzuki, K., 1998, Purification of native p94, a muscle-specific calpain, and characterization of its autolysis, Biochem J., 335, 589-96
60. Kinbara, K., Sorimachi, H., Ishiura, S., Suzuki, K., 1997, Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs, Arch. Biochem. Biophys, 342, 99-107
61. Kotaka, M., Kostin, S., Ngai, S., Chan, K., Lau, Y., Lee, S.M., Li H., Ng, E.K., Schaper, J., Tsui SK, Fung K, Lee C, Waye MM., 2000,Interaction of hCLIM1, an enigma family protein, with alpha-actinin 2., J. Cell. Biochem., 78,558-65
62. Kotaka, M., Lau, Y.M., Cheung, K.K., Lee, S.M., Li, H.Y., Chan, W.Y., Fung, K.P., Lee, C.Y., Waye, M.M., Tsui, S.K., 2001, Elfin is expressed during early heart development, 83, 463-72
63. Kramerova, I., Kudryashova E., Venkatraman, G., and Spencer, M.J., 2005, Calpain 3 participates in muscle remodeling by acting upstream of the ubiquitin-proteasome pathway, Hum. Mol. Genet., 14, 2125-2134
64. Kuboki, M; Ishii, H; Kazama, M., 1990, Characterization of calpain I-binding proteins in human erythrocyte plasma membrane, J. Biochem., 107, 776-780
65. Kuboki, M., Ishii, H., and Kazama, M., 1987, Procalpain is activated on the plasma membrane and the calpain acts on the membrane, Biochim. Biophys. Acta, 929, 164-172
66. Labeit, S., Kolmerer, B., 1995, Titins: giant proteins in charge of muscle ultrastructure and elasticity, Science, 270, 293-296
67. Lankiewicz, S., Luetjens, C.M., Nguyen, T.B., Krohn, A.J., Poppe, M., Cole, G.M., Saido, T.C., Prehn, J.H.M., 2000, Activation of calpain I converts excitotoxic neuron death into a caspaseindependent cell death, J. Biol. Chem., 275, 17064-17071
68. Lee, W. J., Adachi, Y., Maki, M., Hatanaka, M., and Murachi, T., 1990, Factors influencing the binding of calpain I to human erythrocyte inside-out vesicles, Biochem. Int., 22, 163-171
69. Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J.A., Hentati, F., and Hamida, M.B., et al., 1998, Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy, Nat. Genet., 20, 31-36
70. Logie, L.J., Brown, A.E., Yeaman, S.J., Walker, M., 2005, Calpain inhibition and insulin action in cultured human muscle cells, Mol. Genet. Metab, 85, 54-60
71. Lynn, S., Evans, J.C., White, C.B., Frayling, T.M., Hattersley, A.T., Turnbull, D.M., Horikawa, Y., Cox, N.J., Bell, G.I., and Walker, M., 2002, Variation in the calpain-10 gene affects blood glucose levels in the British population, Diabetes, 51, 247-250
72. Ma, H., Fukiage, C., Kim, Y.H., Duncan, M.K., Reed, N.A., Shih, M., Azuma, M., and Shearer, T.S., 2001, Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization, J. Biol. Chem., 276, 28525-28531
73. Marshall, C., Hitman, G.A., Partridge, C.J., Clark, A., Ma, H., Shearer, T.R., Turner, M.D., 2005, Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells, Mol. Endocrinol., 19, 213-24
74. Mathews, P.M., Jiang, Y., Schmidt, S.D., Grbovic, O.M., Mercken, M., Nixon, R.A., 2002, Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of B-cleaved C-terminal APP fragments., J. Biol. Chem., 277, 36415- 36424
75. Mcclelland, P., Lash, J., Hataway, D., 1989, Identification of major autolytic cleavage sites in the regulatory subunit of vascular Calpain II. A comparison of partial amino-terminal sequences to deduced sequence from complementary DNA, J. Biol. Chem., 264, 17428-17431
76. Mellgren, R., Song, K., Mericle, M., 1993, m-Calpain requires DNA for activity on nuclear proteins at low calcium concentrations, J. Biol. Chem., 268, 653-657
77. Melloni, E., Michetti, M., Salamino, F., Pontremoli, S., 1998, Molecular and functional properties of a calpain activator protein specific for μ-isoforms, J. Biol. Chem., 273, 12827-12831
78. Moldoveanu, T., Hosfield, C., Lim, D., Elce, J., Jia, Z., Davies, P., 2002, A Calcium switch aligns the active site of calpain, Cell, 108, 649-660
79. Mouatt-Prigent, A., Karlsson, J.O., Agid, and Hirsch E.C., 1996, Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death, Neuroscience, 73, 979-987
80. Mundo, E., Soldati, L., Bellodi, L., Bianchi, G., 1997, The calpain-calpastatin system in obsessivecompulsive disorder, Biol. Psychiatry; 42, 228-229
81. Nath, R., Davis, M., Probert, A.W., Kupina, N.C., Ren, X., Schielke, G.P., Wang, K.K.W., 2000, Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells, Biochem. Biophys. Res. Commun., 274, 16-21
82. Nixon, R.A., Mohan, P., 1999, Calpains in the pathogenesis of Alzheimer's disease. in: Wang KKW, Yuen P-W, eds. Calpain: pharmacology and toxicology of calcium-dependent protease. Philadelphia: Taylor & Francis, 267-91
83. 2+-dependent proteinase involved in myofibrillar protein turnover, Federation Proc., 35, 1746
84. Ono, Y., Sorimachi, H., Suzulu, K., 2004, Structure, Activation, and Biology of Calpain, Biochem. Biophys. Res. Commun, 245, 284-294
85. Ono, Y., Shimada, H., Sorimachi, H., Richard, I., Saido, T.C., Beckmann, J.S., Ishiura, S., and Suzuki, K., 1998, Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A, J. Biol. Chem., 273, 17073-17078
86. Ono, Y., Torii, F., Ojima, K., Doi, N., Yoshioka, K., Kawabata, Y., Labeit, D., Labeit, S., Suzuki, K., Abe, K., Maeda, T., Sorimachi, H., 2006, Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system, J. Biol. Chem., 281, 18519-31
87. Orho-Melander, M., Klannemark, M., Svensson, M.K., Ridderstrale, M., Lindgren, C.M., and Groop, L., 2002, Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels., Diabetes, 51, 2658-2664
88. Otani, K., Han, D.H., Ford, E.L., Garcia-Roves, P.M., Ye, H., Horikawa, Y., Bell, G.I., Holloszy, J.O., Polonsky, K.S., 2004, Calpain system regulates muscle mass and glucose transporter GLUT4 turnover, J. Biol. Chem., 279, 20915-2
89. Otani, K., Polonsky, K.S., Holloszy, J.O., Han, D.H., 2006, Inhibition of calpain results in impaired contraction-stimulated GLUT4 translocation in skeletal muscle, Am. J. Physiol. Endocrinol. Metab., 291, 544-8
90. Papp, Z., van der Velden, J., Stienen, G.J., 2000, Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart,. Cardiovasc. Res., 45, 981-993
91. P.F. van der Ven, Wiesner, S., Salmikangas, P., Auerbach, D., Himmel, M., Kempa, S., Hayess, K., Pacholsky, D., Taivainen, A., and Schröder, R., et al., 2000, Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin, J. Cell Biol., 151, 235-248
92. Pintér, M., and Friedrich, P., 1988, The calcium dependent proteolytic system calpain-calpatatin in Drosophila melanogaster, Biochem J., 253, 467-473
93. 2+ activated thiol protease from drosophila melanogaster, Biochemistry, 31, 8201-8206
94. 2+, Proc. Natl. Acad. Sci., USA, 85, 1740-1743
95. Pontremoli, S., Melloni, E., Viotti, PL., Michetti, M., Di Lisa, F., Siliprandi, N., 1990, Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms, Biochem. Biophys. Res. Commun., 167, 373-380
96. Pontremoli, S., Viotti P., Michetti, M., Sparatore, B., Salamino, F., Melloni, E., 1990, Identification of an endogenous activator of calpain in rat skeletal muscle, Biochem. Biophys. Res. Commun., 171, 569-574
97. 2+-dependent intramolecular autolysis, FEBS Lett., 532, 401-6
98. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., Hillaire, D., Passos-Bueno, M.-R., Zatz, M., Tischfield, J.A., Fardeau, M., Jackson, C.E., Cohen, D., and Beckmann, J.S., 1995, Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A, Cell, 81, 27-40
99. Richard, I., Roudant, C., Saenz, A., et al., 1999, Calpainopathy, a survey of mutations and polymorphism, Am. J. Hum. Genet., 64, 1524-1540
100. 2+-binding domain, J. Biol. Chem., 273, 15879 -15822
101. Romero, P.J., Salas, V., Hernandez, C., 2002,Calcium pump phosphoenzyme from young and old human red cells., 26,945-949
102. Saito, K., Elce, J.S., Hamos, J.E., Nixon, R.A., 1993, Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration, Proc. Natl. Acad. Sci. U.S.A., 90, 2628-2632
103. Saido, T., Shibata, M., Takenawa, T., Murofushi, H., Suzuki, K., 1992, Positive regulation of μ-calpain action by polyphosphoinositides, J. Biol. Chem., 267, 24585-24590
104. Sandmann, S., Yu, M., Unger, T., 2001, Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction - effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor, Br. J. Pharmacol.; 132, 767-777
105. Sedarous, M., Keramaris, E., O'Hare, M., Melloni, E., Slack, R.S., Elce, J.S., Greer, P.A., Park, D.S., 2003, Calpains mediate p53 activation and neuronal death evoked by DNA damage, J. Biol. Chem., 278, 26031-26038
106. Shearer, T.R., Ma, H., Shih, M., Fukiage, C., Azuma, M., 2000, Calpains in the lens and cataractogenesis, Methods Mol. Biol.; 144, 277-285
107. Shields, D.C., Schaecher, K.E., Saido, T.C., Banik, N.L., 1999, A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain, Proc. Natl. Acad. Sci. U S A; 96,11486-11491
108. Shollmeyer, J., 1986, Possible role of calpain I and calpain II in differentiating muscle, Exp. Cell. Res., 163, 413-422
109. 2+-activated protease in myoblast fusion, Exp. Cell. Res.,162, 411-422
110. Sokol, S.B., and Kuwabara, P.E., 2000, Proteolysis in Caenorhabditis elegans sex determination: cleavage of TRA-2A by TRA-3, Genes.Dev., 14, 901-906
111. Sorimachi, H., Forsberg, N.E., Lee, H.J., Joeng, S.Y., Richard, I., Beckmann, J.S., Ishiura, S., and Suzuki, K., 1996, Highly conserved structure in the promoter region of the gene for muscle-specific calpain, p94., Biol. Chem., 377, 859-864
112. Sorimachi, H., Imajoh, O.S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y., and Suzuki, K., 1989, Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle, J. Biol. Chem., 264, 20106-20111
113. Sorimachi, H., Ohmi, S., Emori, Y., Kawasaki, H., Saido, T., Ohno, S., Minami, Y., Suzuki, K., 1990, A novel member of the calcium-dependent cysteine protease family, Biol. Chem. Hoppe Seyler., 371, 171-6
114. Sorimachi, H., Ono, Y., Suzuki, K., 2000, Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A, Adv. Exp. Med. Biol., 481, 383-95
115. Sorimachi, H., and Suzuki, K., 2001, The structure of calpain, J. Biochem., 129, 653-654
116. Sorimachi, H., Toyama-Sorimachi, N., Saido, T. C., Kawasaki, H., Sugita, H., Miyasaka, M., Arahata, K., Ishiura, S., Suzuki, K., 1993, Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle, J. Biol. Chem., 268, 10593-10605
117. Stossel, T.P., Condeelis, J., Cooley, L., Hartwig, J.H., Noegel, A., Schleicher, M., and Shapiro, S.S., 2001, Filamins as integrators of cell mechanics and signalling, Nat. Rev. Mol. Cell. Biol., 2, 138-145
118. Strobl, S., Fernandez-Catalan, C., Braun, M., Huber, R., Masumoto, H., Nakagawa, K., Irie, A., Sorimachi, H., Bourenkow, G., Bartunik, H., Suzuki, K., Bode, W., 1999, The crystal structure of calcium free human m-calpain suggests an electrostatic switch mechanism for activation by calcium, PNAS, 97, 588-592
119. Sugimoto, K., Katsuya, T., Ishikawa, K., Iwashima, Y., Yamamoto, K., Fu, Y., Matsuo, A., Motone, M., Rakugi, H., Ogihara, T., 2003, UCSNP-43 G/A polymorphism of calpain-10 gene is associated with hypertension and dyslipidemia in Japanese population, Am. J. Hypertens., 16, A82
120. Suzuki, K., Hata, S., Kawabata, Y., Sorimachi, H.,. Structure, activation, and biology of calpain, 2004, Diabetes,; 53, 12-8.
121. 2+ ions, J. Biochem., 90, 275-278
122. Taveau, M., Bourg, N., Sillon, G., Roudaut, C., Bartoli, M., and Richard, I., 2003, Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components, Mol. Cell. Biol., 23, 9127-9135
123. Thompson, T.G., Cha, Y.M., Hack, A.A., Brosius, M., Rajala, M., Lidov, H.G., McNally, E.M., Watkins, S., and Kunkel, L.M., 2000, Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein, J. Cell Biol., 148, 115-126
124. Thompson, V.F., and Goll, D.E., 2000, Purification of mu-calpain, m-calpain, and calpastatin from animal tissues, Methods. Mol. Biol., 144, 3-16
125. Tidball, J.G, Spencer, M.J., 2000, Calpains and muscular dystrophies, Int. J. Biochem. Cell. Biol.; 32, 1-5
126. 2+-regulated phospholipid-binding domain, Biochem. Biophys. Res. Commun., 280, 1333-1339
127. Tompa, P., Mucsi, Z., Orosz, G., Friedrich, P., 2002, Calpastatin subdomains A and C are activators of calpain, J. Biol. Chem., 277, 9022-6
128. 2+ overload: possible link to the proteolysis of alpha-fodrin, Am. J. Physiol. Heart. Circ. Physiol., 281, 1286-1294
129. Tsuji, T., Shimohama, S., Kimura, J., Shimizu, K., 1998, m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains, Neurosci. Lett.; 248, 109-112
130. Vanderklish, P.W., and Bahr, B.A., 2000, The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states, Int. J. Exp. Path., 81, 323-339
131. Vorgerd, M., P.F., van der Ven, Bruchertseifer, M., Lowe, T., Kley, R.A., Schroder, R., Lochmuller, H., Himmel, M., Koehler, K., and Furst, D.O., et al., 2005, A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy, Am. J. Hum. Genet., 77, 297-304
132. Walton, J.N., and Nattrass, F.J., 1954, On the classification, natural history and treatment of the myopathies, Brain, 77, 169-231
133. Wang, K.K.W., 2000, Calpain or caspase: can you tell the difference?, Trends. Neurosci., 23, 20-26
134. Wood, D.E., Thomas, A., Devi, L.A., Berman, Y., Beavis, R.C., Reed, J.C., Newcomb, E.W., 1998, Bax cleavage is mediated by calpain during drug-induced apoptosis, Oncogene, 17, 1069-1078
135. Xiao, G., Rabson, A.B., Young, W., Qing, G., Qu, Z., 2006, Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease, Cytokine Growth Factor Rev., 17, 281-93
136. Xu, K., Driscoll, M., Tavernarakis, N., 2002, Specific aspartyl and calpain proteases are required for neurodegeneration in C, elegans, Nature, 419, 939-944
137. Yoshida, K., Inui, M., Harada, K., et al., 1995, Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain, Circ. Res., 77, 603-610
138. Yoshikawa, Y., Mukai, H., Hino, F., Asada, K., Kato, I., 2000, Isolation of two novel genes, downregulated in gastric cancer, Jpn. J. Cancer Res.; 91,459-463
139. Yoshizawa, T., Sorimachi, H., Tomioka, S., Ishiura, S., Suzuki, K., 1995, Calpain dissociates into subunits in the presence calcium ions, Biochem. Biophys. Res. Commun., 208, 376-383
140. Zatz, M., Vainzof, M., Passos-Bueno, M.R., 2000, Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes, Curr. Opin. Neurol., 13, 511-517
141. Zimmerman, U., and Schlapfer, W., 1991, Two stage autolysis of the catalytic subunit initiates activation of calpain I, Biochim. Biophys. Acta, 1078, 192-198